Medical Countermeasures — Americas | NovaPharmaNews

Breaking

European Research Revolution: Day 1 Highlights RAPS Euro Convergence: Key Regulatory Updates - Day 1 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD

Tivic Health Rebrands as Valion Bio, Advances Entolimod for Acute Radiation Syndrome with FDA Fast Track Status

NewsApr 24, 2026

Tivic Health Rebrands as Valion Bio, Advances Entolimod for Acute Radiation Syndrome with FDA Fast Track Status

Tivic Health Systems rebrands as Valion Bio, advancing Entolimod for Acute Radiation Syndrome with FDA Fast Track and Orphan Drug designations.